HS OBTAIN 17+

HS OBTAIN study with Sanofi

Hello Thread

Designed for iPad

    • Free

Screenshots

Description

Your app for the HS OBTAIN study assessing the efficacy and safety of SAR442970 in participants with moderate to severe hidradenitis suppurativa.

This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.

What’s New

Version 1.2.70

Bug Fix

App Privacy

The developer, Hello Thread, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Linked to You

The following data may be collected but it is not linked to your identity:

  • Contact Info
  • Usage Data
  • Diagnostics

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

You Might Also Like

SHSA Conference
Medical
Coach Morgan
Health & Fitness
Jenevive Papaya
Health & Fitness
MedFit
Medical
JSRing
Health & Fitness
SmartSignals® eCOA
Medical